Staff Members - Benha University
Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
• 2020
Publication Information
Authors
Abdel-sadek Hamed Al-aarag1
, Mohammad Hussein Kamel1
, Eman Ramadan Abdelgawad1
,
Shaimaa Magdy Abo-Youssef1
, Hany Hussein Moussa2* , Marwa Elsayed Elnaggar1
,
Rasha Mohammad Hendy1 and Koot Ahmad Diab
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Tuberculous pleurisy and malignancy are two of the most common causes of pleural effusion. IL-33 is
expressed in the epithelial lining and endothelial cells and is released after cell damage; it is proposed to have an
essential role in sensing damage in various infectious and inflammatory diseases. This work aimed to determine the
diagnostic role of IL-33 in pleural effusions.
Methods: One hundred seventeen patients with pleural effusions of different etiologies had a quantitative
measurement of IL-33 in their pleural effusion and serum samples by ELISA technique.
Results: The concentrations of IL-33 (mean ± SD) in tuberculous pleural effusion (TPE) group (22.5 ± 0.90 ng/l) were
significantly higher than that of malignant pleural effusion (MPE) group (14.6 ± 2.35 ng/l; P < 0.001). There is no
significant difference between the serum levels of IL-33 in (TPE) group and (MPE) group (P > 0.05). The
concentrations of IL-33 in the pleural effusions were significantly correlated to that of the serum concentrations in
each group (TPE: r = 0.848, P = < 0.001; MPE: r = 0.881, < 0.001) and pleural ADA in patients with tuberculous pleural
effusions, (r = 0.38, P < 0.001). The cut-off value of pleural IL33 for (TPE) was 19.16 ng/l, with a sensitivity of 91.7%, a
specificity of 96.4%. The cutoff point of a pleural/ serum IL-33 ratio for the diagnosis of TPE was > 1.4 with a
sensitivity of 91.7% and specificity of 100% while for the determination of (MPE) was < 0.9 with a sensitivity of
83.3% and specificity of 96.4%.
Conclusion: IL-33 level may serve as a novel biomarker to differentiate pleural effusions, especially tuberculous
from malignant effusions.
expressed in the epithelial lining and endothelial cells and is released after cell damage; it is proposed to have an
essential role in sensing damage in various infectious and inflammatory diseases. This work aimed to determine the
diagnostic role of IL-33 in pleural effusions.
Methods: One hundred seventeen patients with pleural effusions of different etiologies had a quantitative
measurement of IL-33 in their pleural effusion and serum samples by ELISA technique.
Results: The concentrations of IL-33 (mean ± SD) in tuberculous pleural effusion (TPE) group (22.5 ± 0.90 ng/l) were
significantly higher than that of malignant pleural effusion (MPE) group (14.6 ± 2.35 ng/l; P < 0.001). There is no
significant difference between the serum levels of IL-33 in (TPE) group and (MPE) group (P > 0.05). The
concentrations of IL-33 in the pleural effusions were significantly correlated to that of the serum concentrations in
each group (TPE: r = 0.848, P = < 0.001; MPE: r = 0.881, < 0.001) and pleural ADA in patients with tuberculous pleural
effusions, (r = 0.38, P < 0.001). The cut-off value of pleural IL33 for (TPE) was 19.16 ng/l, with a sensitivity of 91.7%, a
specificity of 96.4%. The cutoff point of a pleural/ serum IL-33 ratio for the diagnosis of TPE was > 1.4 with a
sensitivity of 91.7% and specificity of 100% while for the determination of (MPE) was < 0.9 with a sensitivity of
83.3% and specificity of 96.4%.
Conclusion: IL-33 level may serve as a novel biomarker to differentiate pleural effusions, especially tuberculous
from malignant effusions.